The 2 Drugs Vying to Become the First Oral Treatment for Type 1 Diabetes
Written by: Beyond Type 1 Editorial Team
1 minute read
April 3, 2019
Though Zynquista was not approved for use in the U.S., it is still under review in Europe, and according to the nonprofit Beyond Type 1, it is more likely to be approved there than in the U.S. since reviews in Europe have been more positive.
Author
Beyond Type 1 Editorial Team
Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research. Find industry news, inspirational stories and practical help. Join the 1M+ strong community and discover what it means to #LiveBeyond a diabetes diagnosis.
Related Resources
After the Grammy-award winning singer met with the Fortune 500 exec, two main results emerged:...
Register here
According to findings from a new research survey commissioned by Sanofi and released Wednesday by...
Register here
“My child was diagnosed at six,” says the mega-star, who recently partnered with Beyond Type...
Register here